• Je něco špatně v tomto záznamu ?

α-Synuclein aggregation at low concentrations

K. Afitska, A. Fucikova, VV. Shvadchak, DA. Yushchenko,

. 2019 ; 1867 (7-8) : 701-709. [pub] 20190513

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19044828

BACKGROUND: Aggregation of the neuronal protein α-synuclein into amyloid fibrils is a hallmark of Parkinson's disease. The propensity of α-synuclein to aggregate increases with the protein concentration. For the development of efficient inhibitors of α-synuclein aggregation, it is important to know the critical concentration of aggregation (the concentration of monomeric protein, below which the protein does not aggregate). METHODS: We performed in vitro aggregation studies of α-synuclein at low concentrations (0.11-20 μM). Aggregation kinetics was measured by ThT fluorescence. Obtained aggregates were characterized using CD-spectroscopy, fluorescent spectroscopy, dynamic light scattering and AFM imaging. RESULTS: Monomeric α-synuclein at concentrations 0.45 μM and above was able to bind to fibril ends resulting in fibril growth. At the protein concentrations below 0.4 μM, monomers did not fibrillize, and fibrils disaggregated. In the absence of seeds, fibrils were formed only at monomer concentrations higher than 10 μM. At low micromolar concentrations, we observed formation of prefibrillar amyloid aggregates, which are able to induce fibril formation in α-synuclein solutions of high concentrations. CONCLUSIONS: The critical concentration of α-synuclein fibril growth is ~0.4 μM. Prefibrillar amyloid aggregates appear at concentrations between 0.45 and 3 μM and are an intermediate state between monomers and fibrils. Although morphologically different from fibrils, prefibrillar aggregates have similar properties to those of fibrils. GENERAL SIGNIFICANCE: We determined the critical concentration of α-synuclein fibril growth. We showed that fibrils can grow at much lower monomer concentrations than that required for de novo fibril formation. We characterized a prefibrillar intermediate species formed upon aggregation of α-synuclein at low micromolar concentration.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19044828
003      
CZ-PrNML
005      
20200113084624.0
007      
ta
008      
200109s2019 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bbapap.2019.05.003 $2 doi
035    __
$a (PubMed)31096048
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Afitska, Kseniia $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo namesti 2, Prague 16610, Czech Republic; Department of Biochemistry, Faculty of Science, Charles University, Albertov 6, Prague 12843, Czech Republic.
245    10
$a α-Synuclein aggregation at low concentrations / $c K. Afitska, A. Fucikova, VV. Shvadchak, DA. Yushchenko,
520    9_
$a BACKGROUND: Aggregation of the neuronal protein α-synuclein into amyloid fibrils is a hallmark of Parkinson's disease. The propensity of α-synuclein to aggregate increases with the protein concentration. For the development of efficient inhibitors of α-synuclein aggregation, it is important to know the critical concentration of aggregation (the concentration of monomeric protein, below which the protein does not aggregate). METHODS: We performed in vitro aggregation studies of α-synuclein at low concentrations (0.11-20 μM). Aggregation kinetics was measured by ThT fluorescence. Obtained aggregates were characterized using CD-spectroscopy, fluorescent spectroscopy, dynamic light scattering and AFM imaging. RESULTS: Monomeric α-synuclein at concentrations 0.45 μM and above was able to bind to fibril ends resulting in fibril growth. At the protein concentrations below 0.4 μM, monomers did not fibrillize, and fibrils disaggregated. In the absence of seeds, fibrils were formed only at monomer concentrations higher than 10 μM. At low micromolar concentrations, we observed formation of prefibrillar amyloid aggregates, which are able to induce fibril formation in α-synuclein solutions of high concentrations. CONCLUSIONS: The critical concentration of α-synuclein fibril growth is ~0.4 μM. Prefibrillar amyloid aggregates appear at concentrations between 0.45 and 3 μM and are an intermediate state between monomers and fibrils. Although morphologically different from fibrils, prefibrillar aggregates have similar properties to those of fibrils. GENERAL SIGNIFICANCE: We determined the critical concentration of α-synuclein fibril growth. We showed that fibrils can grow at much lower monomer concentrations than that required for de novo fibril formation. We characterized a prefibrillar intermediate species formed upon aggregation of α-synuclein at low micromolar concentration.
650    _2
$a amyloid $x chemie $x metabolismus $7 D000682
650    _2
$a cirkulární dichroismus $7 D002942
650    _2
$a lidé $7 D006801
650    12
$a proteinové agregáty $7 D066329
650    _2
$a fluorescenční spektrometrie $7 D013050
650    _2
$a alfa-synuklein $x chemie $x metabolismus $7 D051844
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Fucikova, Anna $u Department of Chemical Physics & Optics, Faculty of Mathematics & Physics, Charles University, Ke Karlovu 3, Prague 12116, Czech Republic.
700    1_
$a Shvadchak, Volodymyr V $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo namesti 2, Prague 16610, Czech Republic.
700    1_
$a Yushchenko, Dmytro A $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Flemingovo namesti 2, Prague 16610, Czech Republic; Miltenyi Biotec GmbH, Friedrich-Ebert-Straße 68, Bergisch Gladbach 51429, Germany. Electronic address: yushchenko@uochb.cas.cz.
773    0_
$w MED00007006 $t Biochimica et biophysica acta. Proteins and proteomics $x 1878-1454 $g Roč. 1867, č. 7-8 (2019), s. 701-709
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31096048 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200109 $b ABA008
991    __
$a 20200113084956 $b ABA008
999    __
$a ok $b bmc $g 1483097 $s 1083501
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 1867 $c 7-8 $d 701-709 $e 20190513 $i 1878-1454 $m Biochimica et biophysica acta. Proteins and proteomics $n Biochem Biophys Acta $x MED00007006
LZP    __
$a Pubmed-20200109

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...